According to INmune Bio's latest financial reports the company's current EPS (TTM) is -$2.44. In 2022 the company made an earnings per share (EPS) of -$2.05 an increase over its 2021 EPS that were of -$2.53.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -$2.44 | |
2022 | -$2.05 | -19.15% |
2021 | -$2.53 | 86.14% |
2020 | -$1.36 | 34.67% |
2019 | -$1.01 | -32.36% |
2018 | -$1.49 | 1396.12% |
2017 | -$0.09972 | 199.64% |
2016 | -$0.03328 |